Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
576.26
+15.80 (2.82%)
At close: Nov 11, 2025
2.82% (1Y)
| Market Cap | 583.40B |
| Revenue (ttm) | 62.48B |
| Net Income (ttm) | 19.59B |
| Shares Out | n/a |
| EPS (ttm) | 75.80 |
| PE Ratio | 29.79 |
| Forward PE | 21.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 507 |
| Average Volume | 139 |
| Open | 571.71 |
| Previous Close | 560.46 |
| Day's Range | 571.71 - 576.26 |
| 52-Week Range | 497.63 - 745.00 |
| Beta | 0.32 |
| RSI | 51.80 |
| Earnings Date | Nov 3, 2025 |